Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Archer

Showing results (221-230 of 365) with videos related to

Pageof 37
Sort By:
Journal of Occupational and Environmental Medicine|May 30, 1998
Chronic diffuse interstitial fibrosis of the lung in uranium minersV E Archer, A D Renzetti, R S Doggett, et al.
Cancer Research|April 15, 1997
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylateC J Reist, G E Archer, C J Wikstrand, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|April 5, 2000
Students together against negative decisions (STAND): evaluation of a school-based sexual risk reduction intervention in the rural southM U Smith, F C Dane, M E Archer, et al.
Journal of Neurovirology|May 19, 1998
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetC J Wikstrand, C J Reist, G E Archer, et al.
Cancer|March 1, 1971
Histologic types of lung cancer among uranium minersG Saccomanno, V E Archer, O Auerbach, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 1, 1991
Pharmacokinetics, safety and tissue residues of sustained-release sulfamethazine in sheepM S Bulgin, V M Lane, T E Archer, et al.
Biotechniques|February 24, 2001
Maximization of signal derived from cDNA microarraysS E Wildsmith, G E Archer, A J Winkley, et al.
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobinS A Shoemaker, M J Gerber, G L Evans, et al.
JAMA|July 15, 1983
Frictional dermatitis of OnanJ L Jorizzo, P Subrt, E B Smith, et al.
Pageof 37

Showing results (221-230 of 365) with videos related to

Sort By:
Pageof 37
Journal of Occupational and Environmental Medicine|May 30, 1998
Chronic diffuse interstitial fibrosis of the lung in uranium minersV E Archer, A D Renzetti, R S Doggett, et al.
Cancer Research|April 15, 1997
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylateC J Reist, G E Archer, C J Wikstrand, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|April 5, 2000
Students together against negative decisions (STAND): evaluation of a school-based sexual risk reduction intervention in the rural southM U Smith, F C Dane, M E Archer, et al.
Journal of Neurovirology|May 19, 1998
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetC J Wikstrand, C J Reist, G E Archer, et al.
Cancer|March 1, 1971
Histologic types of lung cancer among uranium minersG Saccomanno, V E Archer, O Auerbach, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 1, 1991
Pharmacokinetics, safety and tissue residues of sustained-release sulfamethazine in sheepM S Bulgin, V M Lane, T E Archer, et al.
Biotechniques|February 24, 2001
Maximization of signal derived from cDNA microarraysS E Wildsmith, G E Archer, A J Winkley, et al.
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobinS A Shoemaker, M J Gerber, G L Evans, et al.
JAMA|July 15, 1983
Frictional dermatitis of OnanJ L Jorizzo, P Subrt, E B Smith, et al.
Pageof 37